Adrenal Suppression and Absorption Study of Halobetasol Propionate Foam in Subjects 12-17 With Plaque Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel J Piacquadio, MD
Therapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Investigative Site 9
Batumi, Georgia
- Investigative Site 10
Tbilisi, Georgia
- Investigative Site 11
Tbilisi, Georgia
- Investigative Site 3
Krakow, Poland
- Investigative Site 5
Tarnów, Poland
- Investigative Site 4
Warsaw, Poland
- Investigative Site 8
Rivne, Ukraine
- Investigative Site 6
Uzhhorod, Ukraine
- Investigative Site 7
Zaporizhzhya, Ukraine
- Investigative Site 2
Hialeah, Florida, United States
- Investigative Site 1
Saint Joseph, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jun 2019
- Primary completion
- 30 Dec 2019
- Completion
- 30 Dec 2019
- Last update posted
- 6 Jul 2023
- Registered enrollment
- 24
- Registry id
- NCT03992261
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.